RxDoctor Payments Data

Ryan Williams, DO

Family Medicine · Tappahannock, VANPI 1568430841

Payments from drug & device makers

$1,645in general payments, 2019–2025

Across 94 payments — averaging $17.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$447
  • Amgen$223
  • AstraZeneca$169
  • Pfizer$120
  • Lilly USA, LLC$110
  • Boston Scientific$95
  • plus $482 from 15 others
$199in research payments, 2019–2025

Across 1 payment — averaging $199.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$199

What the payments were for

  • Food & beverage$1,645100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,645 in reported general payments places this provider in the 75th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$45,090
Medicare patients
271
Services billed
957

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$8,797
Gabapentin38$661
Atorvastatin Calcium69$608
Fluticasone Propionate28$521
Rosuvastatin Calcium55$491
Tamsulosin Hcl16$412
Potassium Chloride17$363
Amlodipine Besylate81$360
Metoprolol Succinate30$326
ValacyclovirValacyclovir Hcl13$316
Losartan Potassium39$294
Albuterol Sulfate HfaAlbuterol Sulfate11$270
Meloxicam29$222
Metformin Hcl ErMetformin Hcl25$206
Omeprazole14$204

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$120$8,79717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Tappahannock

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →